Food and beverage companies are trying to respond with products that meet AOM users needs in terms of portion size, nutritional content and sensory preferences, all while factoring in possible consumer concern about ultra-processed foods
This injectable medication works by mimicking the action of a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP-1)
Irvine, CA June 10, 2024 Researchers from the University of California, Irvine have just published a study that projects 93 million U.S
Malondialdehyde (MDA) is the end product of lipid peroxidation
Long MT, Noureddin M, Lim JK (2022) AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review
The FLOW trial demonstrated meaningful reductions in kidney disease progression with semaglutide. The SELECT trial showed a 20% reduction in major adverse cardiovascular events in patients with obesity and established cardiovascular disease. These are not trivial findings